AI MARKET SCANNING

Celldex Therapeutics, Inc.

📅 Next Catalyst: Nov 09, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -0.53%
MAX GAP RECORD -13.27%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CLDX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 09, 2026 Earnings Release 2026-11-09 (UNDETERMINED) 🔮 UPCOMING 🔒
Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
+0.75%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
+4.86%
Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE)
-2.50%
Nov 10, 2025 Earnings Release 2025-11-10 (AFTER CLOSE)
-1.81%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
-4.43%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-0.95%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
-2.02%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.9%
Bullish Gaps (4)
Bearish Gaps (5)
Neutral / Flat (6)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CLDX

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-28 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1383m +10.43%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159),…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗